Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by bartlmanon May 20, 2016 5:07pm

169 Views

Post# 24893999

RE:More on Tecentric

Sounds like a wonderful treatment. Besides extending life by as much as 12 months in a limited number of patients you get the following....

"The most common side effects with Tecentriq were fatigue, loss of appetite, nausea, urinary tract infection, fever, and constipation. But the drug also can cause severe infections and organ problems because of the way it acts on the immune system."

I'll pass.

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta